Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -88,039 | -48,607 | -35,443 |
| Depreciation Amortization | -4,960 | -2,818 | 59 |
| Accounts receivable | -689 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,275 | 2,012 | -18 |
| Other Working Capital | 2,906 | 3,439 | 4,439 |
| Other Operating Activity | 8,794 | 295 | 1,159 |
| Operating Cash Flow | $-78,713 | $-45,679 | $-29,804 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -300,530 | -121,195 | -55,338 |
| PPE Investments | -234 | N/A | -14 |
| Investing Cash Flow | $-300,764 | $-121,195 | $-55,352 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -365 | -16,291 | N/A |
| Common Stock Issued | 632,068 | 2,082 | 166 |
| Other Financing Activity | -3,424 | 101,206 | 119,526 |
| Financing Cash Flow | $628,279 | $86,997 | $119,692 |
| Beginning Cash Position | 8,266 | 88,143 | 53,607 |
| End Cash Position | 257,068 | 8,266 | 88,143 |
| Net Cash Flow | $248,802 | $-79,877 | $34,536 |
| Free Cash Flow | |||
| Operating Cash Flow | -78,713 | -45,679 | -29,804 |
| Capital Expenditure | -234 | N/A | -14 |
| Free Cash Flow | -78,947 | -45,679 | -29,818 |